Cultivated autologous limbal stem cell therapy (University of California)

培养的自体角膜缘干细胞疗法

Report date: 2022/12/29 18:20:42

Base Information

Drug NameCultivated autologous limbal stem cell therapy (University of California)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsLimbal Stem Cell Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California At Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsLimbal Stem Cell Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A